| Pharmaceuticals | Branded generics, generic drugs, APIs, biosimilars, and nutraceutical products. | Strong R&D capabilities, diversified portfolio, regulatory approvals, global manufacturing presence, and established distribution network. | B2B and B2C including hospitals, pharmacies, and healthcare professionals in India and abroad. | Biosimilars, specialty generics, and branded products in India and US markets. | 129645 | 100 | Product sales through domestic and international markets, contract manufacturing, and licensing. | Direct sales with competitive pricing; some recurring revenues from contract and licensing agreements. | Expanding product portfolio, regulatory approvals, global market expansion, and rising chronic disease burden. | Taxim, Clavam, Metanext, Pulmocare |
